OKYO Pharma Limited Ordinary Shares (OKYO) is a publicly traded Healthcare sector company. As of May 19, 2026, OKYO trades at $1.59 with a market cap of $82.39M and a P/E ratio of 0.00. OKYO moved +0.00% today. Year to date, OKYO is -28.70%; over the trailing twelve months it is +7.43%. Its 52-week range spans $0.90 to $3.35. Analyst consensus is buy with an average price target of $7.00. Rallies surfaces OKYO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns OKYO stock?
Hedge funds tracked by Rallies that own OKYO include Citadel Advisors and Renaissance Technologies. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for OKYO Pharma Limited Ordinary Shares.
OKYO Key Metrics
Key financial metrics for OKYO
Metric
Value
Price
$1.59
Market Cap
$82.39M
P/E Ratio
0.00
EPS
$0.00
Dividend Yield
0.00%
52-Week High
$3.35
52-Week Low
$0.90
Volume
11.05K
Avg Volume
0
Revenue (TTM)
$0
Net Income
$0
Gross Margin
0.00%
Top Hedge Funds Holding OKYO
Citadel Advisors holds 20.73K shares of OKYO, changed +39.35% as of Dec 31, 2024.
Renaissance Technologies holds 16.50K shares of OKYO, changed +39.83% as of Dec 31, 2024.
Hedge funds tracked by Rallies that own OKYO include Citadel Advisors and Renaissance Technologies. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for OKYO Pharma Limited Ordinary Shares.
Does Rallies show 13F holders for OKYO?
Yes. Rallies tracks hedge fund and 13F ownership data for OKYO, including fund names, share counts, latest tracked quarter, and position changes when available.
Is OKYO research on Rallies investment advice?
No. Rallies provides research, data, and educational context for OKYO. It does not provide personalized investment advice.
